Riociguat (Compound)

Synonyms:Riociguat, 625115-55-1, Adempas, BAY 63-2521, Riociguat (BAY 63-2521), Riociguat-d3, BAY-63-2521, Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate, RU3FE2Y4XI, 1304478-72-5, methyl N-(4,6-diamino-2-{1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate, methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate, CHEBI:76018, N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester, Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate, Riociguat [INN], methyl ~{N}-[4,6-bis(azanyl)-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-~{N}-methyl-carbamate, Methyl 4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl(methyl)carbamate, UNII-RU3FE2Y4XI, riociguatum, Riociguate, Riociguat [USAN:INN:JAN], C20H19FN8O2, Riocguat-d3, GZO, Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl(methyl)carbamate, Adempas (TN), BAY 632521, RIOCIGUAT [JAN], RIOCIGUAT [MI], RIOCIGUAT [USAN], RIOCIGUAT [VANDF], RIOCIGUAT [USP-RS], RIOCIGUAT [WHO-DD], Bay 63-2521,Riociguat, Riociguat (JAN/USAN/INN), SCHEMBL245457, GTPL5257, RIOCIGUAT [ORANGE BOOK], CHEMBL2107834, RIOCIGUAT [EP MONOGRAPH], AMY4218, DTXSID50978109, RIOCIGUAT [USP MONOGRAPH], BCP04750, BCP23980, EX-A2023, Riociguat,CAS:625115-55-1, MFCD19443708, s8135, AKOS015900718, AKOS032950011, BAY-632521, BCP9000382, CCG-268912, CS-0584, DB08931, PB25734, NCGC00379065-03, NCGC00379065-04, NCGC00379065-05, [4,6-Diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]methylcarbamic acid methyl ester, AC-27647, AS-19299, HY-14779, BCP0726000023, DB-073136, FT-0760451, BAY 63-2521;BAY 632521, D09572, BAY 63-2521; BAY 632521, EN300-7413126, Q2154494, BAY 63-2521-d3; BAY 632521-d3; Methyl [4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]methylcarbamate-d3, Carbamic acid, (4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl)methyl-, methyl ester, Carbamic acid, N-(4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl)-N-methyl-, methyl ester, methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate, Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate
Pubchem:PUBCHEM:11304743
Id:d9cb5796-1efc-54a3-9939-1d4bc7d16202
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Riociguat's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Riociguat.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Riociguat.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.